Globus Medical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
605.00
120.00
165.00
243.00
180.00
125.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-66.00
-97.00
-116.00
-105.00
-17.00
-37.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
753.00
520.00
243.00
178.00
276.00
198.00
Cash Flow from Investing Activities
-355.00
-176.00
302.00
-110.00
-375.00
-117.00
Cash Flow from Financing Activities
-679.00
-27.00
-231.00
-109.00
54.00
-38.00
Net Cash Inflow / Outflow
-258.00
317.00
316.00
-42.00
-46.00
43.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
22.00
0.00
2.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Globus Medical, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
605.068
170.937
435.00
253.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-66.795
-23.344
-43.00
-186.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
753.447
297.371
456.00
153.37%
Cash Flow from Investing Activities
-355.014
-247.386
-108.00
-43.51%
Cash Flow from Financing Activities
-679.16
15.999
-694.00
-4345.02%
Net Cash Inflow / Outflow
-258.282
69.782
-327.00
-470.13%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
22.445
3.798
19.00
490.97%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 44.72% vs 113.82% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
753.45
520.64
44.72%






